Articles related to Government Relations & Health Policy

< back to service

Companion Legislation Repealing Moratorium on Physician-Owned Hospitals Introduced in Senate

[06/21/17]

Hall Render’s This Week in Washington – April 17, 2015

[04/17/15]

OIG Warns That Manufacturer Safeguards May Not Prevent Copayment Coupon Use for Part D Drugs

[10/21/14]

FDA Publishes Compounding Guidance, but Where Are the Regulations?

[08/01/14]

Congress Calls for Comments on Federal Legislative Changes Necessary to Encourage the Use of Telehealth Technology

[05/19/14]

Health Care Legislative Update ISBA Health Law Symposium

[05/01/14]

Will Indiana’s New Prescribing Rules Be a Pain in the Neck for Pharmacists?

[04/28/14]

Potential Prescription Drug Audit Areas Highlighted in the OIG’s Fiscal Year 2014 Work Plan

[02/18/14]

Proposed New Law Creates “Safe Pharmacies” Aimed to Fight Controlled Substance Abuse and Includes Other Anti-Fraud Measures

[02/05/14]

2013 Health Law Year in Review: 13 Notable Changes in Health Law in 2013

[01/10/14]

President Signs Compounding Pharmacy Bill – First Related FDA Guidance Published

[12/04/13]

President Signs Compounding Pharmacy Bill – First Related FDA Guidance Published

[12/01/13]

The Drug Quality and Security Act: Implications of the Proposed New Law for Compounding Pharmacies and the Pharmaceutical Supply Chain

[11/26/13]

OIG Reaffirms Concerns on Prevalence and Use of Spinal Devices Supplied to Hospitals by Physician-Owned Distributors

[10/28/13]

The Changing Landscape of Off-Label Prescription Drug Marketing

[07/16/13]

Off-Label Use of Medical Products: Warranty and Indemnification Considerations in Purchase Agreements

[04/11/13]

OIG Releases Physician-Owned Entity Special Fraud Alert

[03/27/13]

Final Sunshine Rule Requires Reporting of Physician Ownership in GPOs and Health Products Manufacturers

[03/13/13]

CMS Publishes the Final Physician Payment Sunshine Rule

[02/20/13]

OIG Advisory Opinion 12-14: OIG Approves Retail Rewards Program That Includes Purchases at In-Store Pharmacies

[10/19/12]

Potential Prescription Drug Audit Areas Highlighted in the OIG’s Fiscal Year 2013 Work Plan

[10/05/12]

OIG Reminds Pharmacies of Proper Schedule II Billing Practices

[09/28/12]

Pharmacies and Drug Distributors Take Note: DEA Revokes Registration of Two CVS Pharmacies

[09/14/12]

The Joint Commission Seeks Comments on Primary Care Medical Home Certification Process for Hospitals

[08/02/12]

OIG Study Perceives Questionable Part D Billing by Retail Pharmacies

[05/14/12]